94 related articles for article (PubMed ID: 27391546)
21. Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.
Lope V; Fernández de Larrea N; Pérez-Gómez B; Martín V; Moreno V; Costas L; Longo F; Jiménez-Moleón JJ; Llorca J; Ascunce N; Peiró-Pérez R; Altzibar JM; Tardón A; Alguacil J; Navarro C; Sierra Á; Vega AB; Villafañe A; Castaño-Vinyals G; Kogevinas M; Pollán M; Aragonés N
PLoS One; 2016; 11(10):e0164620. PubMed ID: 27776142
[TBL] [Abstract][Full Text] [Related]
22. Height-related risk factors for prostate cancer.
Norrish AE; McRae CU; Holdaway IM; Jackson RT
Br J Cancer; 2000 Jan; 82(1):241-5. PubMed ID: 10638996
[TBL] [Abstract][Full Text] [Related]
23. Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study.
Peremiquel-Trillas P; Benavente Y; Martín-Bustamante M; Casabonne D; Pérez-Gómez B; Gómez-Acebo I; Oliete-Canela A; Diéguez-Rodríguez M; Tusquets I; Amiano P; Mengual L; Ardanaz E; Capelo R; Molina de la Torre AJ; Salas Trejo D; Fernández-Tardón G; Lope V; Jimenez-Moleon JJ; Marcos-Gragera R; Dierssen-Sotos T; Azpiri M; Muñoz M; Guevara M; Fernández-Villa T; Molina-Barceló A; Aragonés N; Pollán M; Castaño-Vinyals G; Alguacil J; Kogevinas M; de Sanjosé S; Costas L
Environ Int; 2019 Jan; 122():389-399. PubMed ID: 30553564
[TBL] [Abstract][Full Text] [Related]
24. The Association of Nighttime Fasting Duration and Prostate Cancer Risk: Results from the Multicase-Control (MCC) Study in Spain.
Palomar-Cros A; Espinosa A; Straif K; Pérez-Gómez B; Papantoniou K; Gómez-Acebo I; Molina-Barceló A; Olmedo-Requena R; Alguacil J; Fernández-Tardón G; Casabonne D; Aragonés N; Castaño-Vinyals G; Pollán M; Romaguera D; Kogevinas M
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444822
[TBL] [Abstract][Full Text] [Related]
25. Measures of birth size in relation to risk of prostate cancer: the Malmö Diet and Cancer Study, Sweden.
Lahmann PH; Wallström P; Lissner L; Olsson H; Gullberg B
J Dev Orig Health Dis; 2012 Dec; 3(6):442-9. PubMed ID: 25084297
[TBL] [Abstract][Full Text] [Related]
26. Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden.
Möller E; Adami HO; Mucci LA; Lundholm C; Bellocco R; Johansson JE; Grönberg H; Bälter K
Cancer Causes Control; 2013 Dec; 24(12):2143-55. PubMed ID: 24048969
[TBL] [Abstract][Full Text] [Related]
27. Sedentarism and overweight as risk factors for the detection of prostate cancer and its aggressivenes.
Morote J; Celma A; Planas J; Placer J; Konstantinidis C; Iztueta I; de Torres IM; Oliván M; Reventós J; Doll A
Actas Urol Esp; 2014 May; 38(4):232-7. PubMed ID: 24156935
[TBL] [Abstract][Full Text] [Related]
28. PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.
Patel AA; Chen MH; Renshaw AA; D'Amico AV
JAMA; 2007 Oct; 298(13):1533-8. PubMed ID: 17911498
[TBL] [Abstract][Full Text] [Related]
29. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
30. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
31. Increased Dietary Inflammatory Index (DII) Is Associated With Increased Risk of Prostate Cancer in Jamaican Men.
Shivappa N; Jackson MD; Bennett F; Hébert JR
Nutr Cancer; 2015; 67(6):941-8. PubMed ID: 26226289
[TBL] [Abstract][Full Text] [Related]
32. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
33. Simple Risk Stratification to Detect Prostate Cancer with High Gleason Score in Repeat Biopsies in a Population Screening Follow-up Study.
Kitagawa Y; Urata S; Mizokami A; Nakashima K; Koshida K; Nakashima T; Miyazaki K; Namiki M
Anticancer Res; 2015 Sep; 35(9):5031-6. PubMed ID: 26254404
[TBL] [Abstract][Full Text] [Related]
34. [Work-related risk factors of prostate carcinoma: results of a case-control study].
Heiskel H; Seidler A; Bickeböller R; Elsner G
Soz Praventivmed; 1998; 43(6):282-92. PubMed ID: 10025009
[TBL] [Abstract][Full Text] [Related]
35. Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study.
Gómez-Acebo I; Dierssen-Sotos T; Palazuelos C; Fernández-Navarro P; Castaño-Vinyals G; Alonso-Molero J; Urtiaga C; Fernández-Villa T; Ardanaz E; Rivas-Del-Fresno M; Molina-Barceló A; Jiménez-Moleón JJ; García-Martinez L; Amiano P; Rodriguez-Cundin P; Moreno V; Pérez-Gómez B; Aragonés N; Kogevinas M; Pollán M; Llorca J
PLoS One; 2018; 13(8):e0201750. PubMed ID: 30106959
[TBL] [Abstract][Full Text] [Related]
36. Residential proximity to industrial pollution sources and colorectal cancer risk: A multicase-control study (MCC-Spain).
García-Pérez J; Fernández de Larrea-Baz N; Lope V; Molina AJ; O'Callaghan-Gordo C; Alonso MH; Rodríguez-Suárez MM; Mirón-Pozo B; Alguacil J; Gómez-Acebo I; Ascunce N; Vanaclocha-Espi M; Amiano P; Chirlaque MD; Simó V; Jiménez-Moleón JJ; Tardón A; Moreno V; Castaño-Vinyals G; Martín V; Aragonés N; Pérez-Gómez B; Kogevinas M; Pollán M
Environ Int; 2020 Nov; 144():106055. PubMed ID: 32827807
[TBL] [Abstract][Full Text] [Related]
37. Is it reporting bias doubled the risk of prostate cancer in vasectomised men in Mumbai, India?
Sunny L
Asian Pac J Cancer Prev; 2005; 6(3):320-5. PubMed ID: 16235993
[TBL] [Abstract][Full Text] [Related]
38. Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR).
Nair-Shalliker V; Yap S; Nunez C; Egger S; Rodger J; Patel MI; O'Connell DL; Sitas F; Armstrong BK; Smith DP
Int J Cancer; 2017 Feb; 140(3):565-574. PubMed ID: 27741552
[TBL] [Abstract][Full Text] [Related]
39. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for prostate cancer in men aged less than 60 years: a case-control study from Italy.
Gallus S; Foschi R; Talamini R; Altieri A; Negri E; Franceschi S; Montella M; Dal Maso L; Ramazzotti V; La Vecchia C
Urology; 2007 Dec; 70(6):1121-6. PubMed ID: 18158031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
